Teradyne · Earnings release

Teradyne Reports Third Quarter 2024 Results

•

Revenue at the high-end and earnings above Q3 guidance

•

•

Year-over-year growth driven by strong AI-related demand

Revenue (mil)

$

$

$

GAAP EPS

$

$

$

Non-GAAP EPS

$

$

$

NORTH READING, Mass. – October 23, 2024 – Teradyne, Inc. (NASDAQ: TER) reported revenue of $737 million for the third quarter of 2024 of which $543 million was in Semiconductor Test, $73 million in System Test, $33 million in Wireless Test and $89 million in Robotics. GAAP net income for the third quarter of 2024 was $145.6 million or $0.89 per diluted share. On a non-GAAP basis, Teradyne’s net income in the third quarter of 2024 was $147.6 million, or $0.90 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, amortization on our investment in Technoprobe, legal settlement, pension mark-to-market, and included the related tax impact on non-GAAP adjustments.

“Semiconductor Test continues to perform better than planned on record Memory revenue driven by High Bandwidth Memory (HBM) and compute demand for AI applications,” said Teradyne CEO, Greg Smith. “Robotics continues to execute to its longer-term growth strategy with improving traction in recurring software and services revenue and progress in the UR OEM channel. As we finish 2024 and look forward to 2025, we are excited about building on this progress."

G1Guidance for the fourth quarter of 2024 is revenue of $710 million to $760 million, with G2GAAP net income of $0.73 to $0.91 per diluted share and G3non-GAAP net income of $0.80 to $0.97 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization and amortization on our investment in Technoprobe, as well as the related tax impact on non-GAAP adjustments.

Webcast

A conference call to discuss the third quarter results, along with management’s business outlook, will follow at 8:30 a.m. ET, Thursday, October 24, 2024. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on the Teradyne website at www.teradyne.com/investors.

Page 2

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, restructuring and other, pension actuarial gains and losses, stock compensation modification expense, gains and losses on foreign exchange options in connection with acquisitions and divestitures, gain on sale of business, legal settlement, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income.

Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares.

Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NASDAQ:TER) test technology helps bring high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its robotics offerings include collaborative and mobile robots that help manufacturers of all sizes increase productivity, improve safety, and lower costs. In 2023, Teradyne had revenue of $2.7 billion and today employs over 6,400 people worldwide. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements including statements regarding Teradyne’s future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “goal” or other comparable terms. Forward-looking statements in this press release address various matters, including statements regarding Teradyne’s financial guidance. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements due to known and unknown risks, uncertainties, assumptions, and other factors. Such factors include, but are not limited to, macroeconomic factors and slowdowns or downturns in economic conditions generally and in the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; a slowdown or inability in the development, delivery and acceptance of new products; the ability to grow the Robotics business; the impact of increased research and development spending; the impact of epidemics or pandemics such as COVID-19; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in Teradyne’s best interests; changes to U.S. or global tax regulations or guidance; the impact of any tariffs or export

Page 3

controls imposed by the U.S. or China; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the current conflicts in Israel; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China.

The risks included above are not exhaustive. For a more detailed description of the risk factors associated with Teradyne, please refer to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Many of these factors are macroeconomic in nature and are, therefore, beyond Teradyne’s control. We caution readers not to place undue reliance on any forward-looking statements included in this press release which speak only as to the date of this press release. Teradyne specifically disclaims any obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

Page 4

TERADYNE, INC. REPORT FOR THIRD FISCAL QUARTER OF 2024

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Quarter Ended

Nine Months Ended

October 1,

October 1,

Net revenues

$

$

$

$

$

Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)

Gross profit

Operating expenses:

Selling and administrative (2)

Engineering and development

Acquired intangible assets amortization

Restructuring and other (3)

Gain on sale of business (4)

—

)

—

)

—

Operating expenses

Income from operations

Interest and other (income) expense (5)

)

)

)

)

)

Income before income taxes and equity in net earnings of affiliate

Income tax provision

Income before equity in net earnings of affiliate

Equity in net earnings of affiliate

)

—

—

)

—

Net income

$

$

$

$

$

Net income per common share:

Basic

$

$

$

$

$

Diluted

$

$

$

$

$

Weighted average common shares - basic

Weighted average common shares - diluted (6)

Cash dividend declared per common share

$

$

$

$

$

(1)

Cost of revenues includes:

Quarter Ended

Nine Months Ended

October 1,

October 1,

Provision for excess and obsolete inventory

$

$

$

$

$

Legal settlement

—

—

—

Sale of previously written down inventory

)

)

)

)

)

$

$

$

$

$

(2)

For the nine months ended September 29, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne executives' retirement agreements. For the nine months ended October 1, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne’s retired CEO’s outstanding equity awards in connection with his February 1, 2023, retirement.

Page 5

(3)

Restructuring and other consists of:

Quarter Ended

Nine Months Ended

October 1,

October 1,

Employee severance

$

$

$

$

$

Acquisition and divestiture related expenses

—

—

—

—

Contract termination

—

—

—

Other

—

$

$

$

$

$

(4)

On May 27, 2024, Teradyne sold Teradyne's Device Interface Solution ("DIS") business, a component of the Semiconductor Test segment, to Technoprobe S.p.A. ("Technoprobe"), for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(5)

Interest and other includes:

Quarter Ended

Nine Months Ended

October 1,

October 1,

Pension actuarial losses (gains)

$

)

$

)

$

$

)

$

Loss (gain) on foreign exchange option

—

)

—

—

(6)

Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended October 1, 2023, 0.6 million shares have been included in diluted shares. For the nine months ended October 1, 2023, 0.8 million shares have been included in diluted shares. For the quarters ended September 29, 2024, June 30, 2024, and October 1, 2023, diluted shares included 0.5 million, 4.9 million, and 9.2 million shares, respectively, from the convertible note hedge transaction. For the nine months ended September 29, 2024, and October 1, 2023, diluted shares included 4.8 million and 9.0 million shares, respectively, from the convertible note hedge transaction.

Page 6

CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)

Assets

Cash and cash equivalents

$

$

Marketable securities

Accounts receivable, net

Inventories, net

Prepayments

Other current assets

Current assets held for sale

—

Total current assets

Property, plant and equipment, net

Operating lease right-of-use assets, net

Marketable securities

Deferred tax assets

Retirement plans assets

Equity method investment

—

Other assets

Acquired intangible assets, net

Goodwill

Assets held for sale

—

Total assets

$

$

Liabilities

Accounts payable

$

$

Accrued employees’ compensation and withholdings

Deferred revenue and customer advances

Other accrued liabilities

Operating lease liabilities

Income taxes payable

Current liabilities held for sale

—

Total current liabilities

Retirement plans liabilities

Long-term deferred revenue and customer advances

Long-term other accrued liabilities

Deferred tax liabilities

Long-term operating lease liabilities

Long-term income taxes payable

Liabilities held for sale

—

Total liabilities

Shareholders’ equity

Total liabilities and shareholders’ equity

$

$

Page 7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

Quarter Ended

Nine Months Ended

October 1,

October 1,

Cash flows from operating activities:

Net income

$

$

$

$

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

Stock-based compensation

Provision for excess and obsolete inventory

Amortization

Equity in net earnings of affiliate

—

—

Gain on sale of business

—

—

)

—

Deferred taxes

)

)

)

)

Losses (gains) on investments

)

)

Retirement plan actuarial losses (gains)

)

—

)

—

Other

)

)

)

Changes in operating assets and liabilities

Accounts receivable

)

)

Inventories

)

Prepayments and other assets

)

)

Accounts payable and other liabilities

)

)

Deferred revenue and customer advances

)

)

Retirement plans contributions

)

)

)

)

Income taxes

)

)

)

)

Net cash provided by operating activities

Cash flows from investing activities:

Purchases of property, plant and equipment

)

)

)

)

Purchases of marketable securities

)

)

)

)

Purchases of investment in a business

)

—

)

—

Issuance of convertible loan

—

)

—

)

Proceeds from maturities of marketable securities

Proceeds from the sale of a business, net of cash and cash equivalents sold

—

—

Proceeds from sales of marketable securities

Proceeds from life insurance

—

—

Net cash used for investing activities

)

)

)

)

Cash flows from financing activities:

Repurchase of common stock

)

)

)

)

Dividend payments

)

)

)

)

Payments related to net settlement of employee stock compensation awards

)

)

)

)

Payments of borrowings on revolving credit facility

—

—

)

—

Payments of convertible debt principal

—

)

—

)

Proceeds from borrowings on revolving credit facility

—

—

—

Issuance of common stock under stock purchase and stock option plans

Net cash used for financing activities

)

)

)

)

Effects of exchange rate changes on cash and cash equivalents

Increase (decrease) in cash and cash equivalents

)

)

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

$

$

$

$

Page 8

GAAP to Non-GAAP Earnings Reconciliation

(In millions, except per share amounts)

Quarter Ended

% of Net Revenues

% of Net Revenues

October 1,

% of Net Revenues

Net revenues

$

$

$

Gross profit - GAAP

%

%

%

Legal settlement (1)

%

—

—

—

—

Gross profit - non-GAAP

%

%

%

Income from operations - GAAP

%

%

%

Acquired intangible assets amortization

%

%

%

Restructuring and other (2)

%

%

%

Legal settlement (1)

%

—

—

—

—

Gain on sale of business (3)

—

—

)

%

—

—

Income from operations - non-GAAP

$

%

$

%

$

%

Net Income

per Common Share

Net Income

per Common Share

Net Income

per Common Share

% of Net Revenues

Basic

Diluted

% of Net Revenues

Basic

Diluted

October 1,

% of Net Revenues

Basic

Diluted

Net income - GAAP

$

%

$

$

$

%

$

$

$

%

$

$

Acquired intangible assets amortization

%

%

%

Restructuring and other (2)

%

%

%

Legal settlement (1)

%

—

—

—

—

—

—

—

—

Amortization of equity method investment

%

—

—

—

—

—

—

—

—

Loss (gain) on foreign exchange option

—

—

—

—

)

%

)

)

—

—

—

—

Gain on sale of business (3)

—

—

—

—

)

%

)

)

—

—

—

—

Pension mark-to-market adjustment (4)

)

%

)

)

)

%

)

)

%

Exclude discrete tax adjustments

)

%

)

)

%

)

%

)

)

Non-GAAP tax adjustments

)

%

)

)

)

%

)

)

)

%

)

)

Net income - non-GAAP

$

%

$

$

$

%

$

$

$

%

$

$

GAAP and non-GAAP weighted average common shares - basic

GAAP weighted average common shares - diluted (6)

Exclude dilutive shares related to convertible note transaction

—

—

)

Non-GAAP weighted average common shares - diluted

Page 9

(1)

For the three months ended September 29, 2024, legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.

(2)

Restructuring and other consists of:

Quarter Ended

October 1,

Employee severance

$

$

$

Contract termination

—

—

Other

—

$

$

$

(3)

On May 27, 2024, Teradyne sold DIS, a component of the Semiconductor Test segment, to Technoprobe, for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(4)

For the quarters ended September 29, 2024, June 30, 2024 and October 1, 2023, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.

(5)

For the quarters ended September 29, 2024, June 30, 2024, and October 1, 2023, non-GAAP weighted average diluted common shares included 0.5 million, 4.9 million and 9.2 million shares, respectively, from the convertible note hedge transaction.

Nine Months Ended

% of Net Revenues

October 1,

% of Net Revenues

Net Revenues

$

$

Gross profit - GAAP

%

%

Legal settlement (1)

%

—

—

Gross profit - non-GAAP

%

%

Income from operations - GAAP

%

%

Acquired intangible assets amortization

%

%

Restructuring and other (2)

%

%

Legal settlement (1)

%

—

—

Equity modification charge (3)

%

%

Loss (gain) on sale of business (4)

)

%

—

—

Income from operations - non-GAAP

$

%

$

%

Net Income

per Common Share

Net Income

per Common Share

% of Net Revenues

Basic

Diluted

October 1,

% of Net Revenues

Basic

Diluted

Net income - GAAP

$

%

$

$

$

%

$

$

Acquired intangible assets amortization

%

%

Restructuring and other (2)

%

%

Loss (gain) on foreign exchange option

%

—

—

—

—

Legal settlement (1)

%

—

—

—

—

Amortization of equity method investment

%

—

—

—

—

Equity modification charge (3)

%

%

Pension mark-to-market adjustment (5)

)

%

)

)

%

Loss (gain) on sale of business (4)

)

%

)

)

—

—

—

—

Exclude discrete tax adjustments

)

%

)

)

)

%

)

)

Non-GAAP tax adjustments

)

%

)

)

)

%

)

)

Convertible share adjustment (6)

—

—

—

—

—

—

—

Net income - non-GAAP

$

%

$

$

$

%

$

$

GAAP and non-GAAP weighted average common shares - basic

GAAP weighted average common shares - diluted (6)

Exclude dilutive shares from convertible note

—

)

Non-GAAP weighted average common shares - diluted

(1)

For the nine months ended September 29, 2024, a legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.

(2)

Restructuring and other consists of:

Nine Months Ended

October 1,

Employee severance

$

$

Acquisition and divestiture related expenses

—

Contract termination

—

Other

$

$

(3)

For the nine months ended September 29, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne’s executives' retirement agreements. For the nine months ended October 1, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne’s retired CEO’s outstanding equity awards in connection with his February 1, 2023, retirement.

(4)

On May 27, 2024, Teradyne sold DIS, a component of the Semiconductor Test segment, to Technoprobe, for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(5)

For the nine months ended September 29, 2024, and October 1, 2023, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.

(6)

For the nine months ended September 29, 2024 and October 1, 2023, non-GAAP weighted average diluted common shares included 4.8 million and 9.0 million shares, respectively, from the convertible note hedge transaction.

GAAP to Non-GAAP Reconciliation of Fourth Quarter 2024 guidance:

GAAP and non-GAAP fourth quarter revenue guidance:

to

GAAP net income per diluted share

$

$

Exclude acquired intangible assets amortization

Exclude equity method investment amortization

Non-GAAP tax adjustments

)

)

Non-GAAP net income per diluted share

$

$

For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.

Contact:

Teradyne, Inc.

Vice President of Corporate Relations